Efficacy of a broad-spectrum antibiotic (mupirocin) in an in vitro model of infected skin.

[1]  J. Hamilton-miller,et al.  Comparison of the in-vitro activities of the topical antimicrobials azelaic acid, nitrofurazone, silver sulphadiazine and mupirocin against methicillin-resistant Staphylococcus aureus. , 1992, The Journal of antimicrobial chemotherapy.

[2]  B. Slocombe,et al.  The antimicrobial activity of mupirocin--an update on resistance. , 1991, The Journal of hospital infection.

[3]  R. Hill,et al.  Minimal dose requirements for nasal mupirocin and its role in the control of epidemic MRSA. , 1991, The Journal of hospital infection.

[4]  J. Boelaert,et al.  The use of nasal mupirocin ointment to prevent Staphylococcus aureus bacteraemias in haemodialysis patients: an analysis of cost-effectiveness. , 1991, The Journal of hospital infection.

[5]  Y. Lamb.  Overview of the role of mupirocin. , 1991, The Journal of hospital infection.

[6]  R. Hill,et al.  Reduction in the colonization of central venous cannulae by mupirocin. , 1991, The Journal of hospital infection.

[7]  H. Rode,et al.  Efficacy of mupirocin in cutaneous candidiasis , 1991, The Lancet.

[8]  D. Herndon,et al.  Topical Bactroban (mupirocin): efficacy in treating burn wounds infected with methicillin-resistant staphylococci. , 1990, The Journal of burn care & rehabilitation.

[9]  D. Breneman.  Use of mupirocin ointment in the treatment of secondarily infected dermatoses. , 1990, Journal of the American Academy of Dermatology.

[10]  A. Lin,et al.  Mupirocin-resistant Staphylococcus aureus after long-term treatment of patients with epidermolysis bullosa. , 1990, Journal of the American Academy of Dermatology.

[11]  S. Mclinn.  A bacteriologically controlled, randomized study comparing the efficacy of 2% mupirocin ointment (Bactroban) with oral erythromycin in the treatment of patients with impetigo. , 1990, Journal of the American Academy of Dermatology.

[12]  P. D. de Wet,et al.  Efficacy of mupirocin in methicillin-resistant Staphylococcus aureus burn wound infection , 1989, Antimicrobial Agents and Chemotherapy.

[13]  J. Capobianco,et al.  Mechanism of mupirocin transport into sensitive and resistant bacteria , 1989, Antimicrobial Agents and Chemotherapy.

[14]  H. Rode,et al.  Bactericidal efficacy of mupirocin in multi-antibiotic resistant Staphylococcus aureus burn wound infection. , 1988, The Journal of antimicrobial chemotherapy.

[15]  J. Buchvald.  An Evaluation of Topical Mupirocin in Moderately Severe Primary and Secondary Skin Infections , 1988, The Journal of international medical research.

[16]  R. Boon,et al.  Antibacterial activity of mupirocin (pseudomonic acid), a new antibiotic for topical use , 1985, Antimicrobial Agents and Chemotherapy.

[17]  G. E. Smith,et al.  Staphylococcus aureus resistant to mupirocin. , 1988, The Journal of antimicrobial chemotherapy.